Recent publications published by researchers at the MRC WIMM.
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Journal article
Tan TK. et al, (2021), Nat Commun, 12
Lung-targeting lentiviral vector for passive immunisation against influenza
Journal article
TAN TK. et al, (2020), Thorax
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Journal article
Rijal P. et al, (2020), J Virol, 94
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans
Journal article
RIJAL P. and TOWNSEND A., (2019), Journal of Virology
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
Journal article
RIJAL P. and TOWNSEND A., (2019), Journal of Virology
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.
Journal article
Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7
A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Journal article
Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
Journal article
Huang K-YA. et al, (2019), Nat Microbiol, 4, 306 - 315
Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.
Journal article
Beer K. et al, (2018), J Gen Virol, 99, 1001 - 1011